Sella turcica metastasis from follicular carcinoma of thyroid

Simple item page
dc.contributor.buuauthorYılmazlar, Selçuk
dc.contributor.buuauthorKocaeli, Hasan
dc.contributor.buuauthorCordan, Teoman
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Beyin ve Sinir Cerrahisi Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-3633-7919tr_TR
dc.contributor.researcheridAAH-5070-2021tr_TR
dc.contributor.scopusid6603059483tr_TR
dc.contributor.scopusid6603500567tr_TR
dc.contributor.scopusid7801648865tr_TR
dc.date.accessioned2021-10-28T08:25:13Z
dc.date.available2021-10-28T08:25:13Z
dc.date.issued2004-01
dc.description.abstractA case of metastasis to the sella turcica from a follicular adenocarcinoma of the thyroid gland is presented. Metastasis to this site is rare and review of the literature reveals only 12 cases of metastatic thyroid carcinoma involving the sella turcica and pituitary gland. The optimal treatment strategy is still to be determined. A 43-year-old woman presented with headache, nausea, visual impairment and galactorrhea. An MRI scan of the cranium revealed an enhancing destructive sellar lesion. The patient underwent transsphenoidal removal of the lesion to alleviate visual loss. The histological features of the sellar tumor were identical to those of a follicular adenocarcinoma partially removed from the thyroid gland 22 months earlier. Total thyroidectomy followed by three courses of iodine-131 ablation enhanced with synthetic thyrotropin and thyroid hormone suppression therapy was instituted. The post-operative course was satisfactory with improved vision and ceased galactorrhea. This case was successfully treated with a combination of surgical removal, iodine-131 ablation and hormone suppression therapy, which resulted in disease control duration of four years. Sella turcica metastases of thyroid carcinoma are exceedingly rare and currently there are no established therapeutic guidelines.en_US
dc.identifier.citationYılmazlar, S. vd. (2004). “Sella turcica metastasis from follicular carcinoma of thyroid”. Neurological Research, 26(1), 74-78.en_US
dc.identifier.endpage78tr_TR
dc.identifier.issn0161-6412
dc.identifier.issn1743-1328
dc.identifier.issue1tr_TR
dc.identifier.pubmed14977061tr_TR
dc.identifier.scopus2-s2.0-0842267610tr_TR
dc.identifier.startpage74tr_TR
dc.identifier.urihttps://doi.org/10.1179/016164104773026561
dc.identifier.urihttps://www.tandfonline.com/doi/abs/10.1179/016164104773026561
dc.identifier.urihttp://hdl.handle.net/11452/22516
dc.identifier.volume26tr_TR
dc.identifier.wos000188886500010tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalNeurological Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLodine-131en_US
dc.subjectSella turcicaen_US
dc.subjectThyroid carcinomaen_US
dc.subjectCancer-patientsen_US
dc.subjectPapillary carcinomaen_US
dc.subjectDistant metastasesen_US
dc.subjectI-131 therapyen_US
dc.subjectPituitaryen_US
dc.subjectThyroglobulinen_US
dc.subjectRadioiodineen_US
dc.subjectMetastasisen_US
dc.subjectNeurosciences & neurologyen_US
dc.subjectThyrogenen_US
dc.subject.emtreeIodine 131en_US
dc.subject.emtreeRecombinant thyrotropinen_US
dc.subject.emtreeThyroid hormoneen_US
dc.subject.emtreeCancer controlen_US
dc.subject.emtreeCancer hormone therapyen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeGalactorrheaen_US
dc.subject.emtreeHeadacheen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypophysis tumoren_US
dc.subject.emtreeMeta analysisen_US
dc.subject.emtreeMetastasisen_US
dc.subject.emtreeNauseaen_US
dc.subject.emtreeNeurologic examinationen_US
dc.subject.emtreeNuclear magnetic resonance imagingen_US
dc.subject.emtreePractice guidelineen_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeSella turcica tumoren_US
dc.subject.emtreeSubtotal thyroidectomyen_US
dc.subject.emtreeThyroid follicular carcinomaen_US
dc.subject.emtreeThyroidectomyen_US
dc.subject.emtreeTranssphenoidal surgeryen_US
dc.subject.emtreeVisual impairmenten_US
dc.subject.meshAdenocarcinoma, follicularen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshFemaleen_US
dc.subject.meshGalactorrheaen_US
dc.subject.meshHeadacheen_US
dc.subject.meshHumansen_US
dc.subject.meshIodine radioisotopesen_US
dc.subject.meshMagnetic resonance imagingen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNeoplasm recurrence, localen_US
dc.subject.meshNeoplasm, residualen_US
dc.subject.meshNeurosurgical proceduresen_US
dc.subject.meshPituitary neoplasmsen_US
dc.subject.meshSella turcicaen_US
dc.subject.meshSkull base neoplasmsen_US
dc.subject.meshThyroid glanden_US
dc.subject.meshThyroidectomyen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.meshVision, lowen_US
dc.subject.scopusHypopituitarism; Diabetes Insipidus; Pituitary Stalken_US
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.titleSella turcica metastasis from follicular carcinoma of thyroiden_US
dc.typeArticle
dc.wos.quartileQ3 (Clinical neurology)en_US
dc.wos.quartileQ4 (Neurosciences)en_US

Files

Collections

Web of Science
Scopus